Rosier Sarah, Lamoury Robby, Ameloot Koen, Knaepen Robbe, De Sutter Thomas, Goethuys Hans, Raskin Yannic
Hospital East-Limburg (ZOL), Department of Urology, Synaps Park 1, 3600, Genk, Belgium.
Hospital East-Limburg (ZOL), Department of Cardiology, Synaps Park 1, 3600, Genk, Belgium.
Urol Case Rep. 2024 Sep 4;57:102845. doi: 10.1016/j.eucr.2024.102845. eCollection 2024 Nov.
Arterial hypertension is a major cause of mortality and morbidity worldwide. Medical therapy is the most common treatment. However, in some cases there is a persistent high blood pressure despite medical therapy. These patients with medication refractory arterial hypertension can be treated by renal denervation. Until now an endovascular approach has been used. There are however limitations in eligibility based on vascular or anatomical anomalies. For these patients, as well as other patients eligible for renal denervation, robot-assisted renal denervation has the potential to become a surgical treatment option based on our findings.
动脉高血压是全球范围内导致死亡和发病的主要原因。药物治疗是最常见的治疗方法。然而,在某些情况下,尽管进行了药物治疗,血压仍持续居高不下。这些药物难治性动脉高血压患者可通过肾去神经支配术进行治疗。到目前为止,一直采用血管内治疗方法。然而,基于血管或解剖异常,在治疗资格方面存在局限性。根据我们的研究结果,对于这些患者以及其他适合肾去神经支配术的患者,机器人辅助肾去神经支配术有可能成为一种手术治疗选择。